In this video, a leader from our Manufacturing Science and Technology (MSAT) team in Copenhagen details our programs for accelerating monoclonal antibodies to clinical IND filings via our AGCellerate™ mAb program, along with our newly expanded single-use manufacturing capacity at the Danish CDMO facility.
Watch the video below to learn more about our expansion of our single-use bioreactor capacity!